Most bought healthcare stocks in Q2 2023
See which Healthcare stocks institutional investors increased the most in Q2 2023, measured as net growth in reported share positions from Q1 2023 into Q2 2023. Notable additions at the top of this list include AVANTOR INC (AVTR), PRIVIA HEALTH GROUP INC (PRVA), DANAHER CORP (DHR), BUTTERFLY NETWORK INC (BFLY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AVTR | AVANTOR INC | 6,889,761 | $3.77M | 0 | 4 | 3 | 0 | 9 |
| PRVA | PRIVIA HEALTH GROUP INC | 4,219,964 | $118.71M | 1 | 1 | 1 | 0 | 3 |
| DHR | DANAHER CORP | 3,659,452 | $852.43M | 2 | 7 | 4 | 1 | 19 |
| BFLY | BUTTERFLY NETWORK INC | 2,912,025 | $11.66M | 0 | 3 | 0 | 1 | 3 |
| TMO | THERMO FISHER SCIENTIFIC INC | 2,904,158 | $1.13B | 1 | 9 | 8 | 1 | 21 |
| AGL | AGILON HEALTH INC | 2,176,399 | -$26.19M | 0 | 3 | 0 | 0 | 3 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 1,961,800 | -$29.44K | 0 | 1 | 1 | 0 | 3 |
| VSTM | VERASTEM INC | 1,958,957 | $14.03M | 2 | 0 | 0 | 0 | 2 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,910,625 | -$29.62M | 1 | 3 | 4 | 0 | 9 |
| OPCH | OPTION CARE HEALTH INC | 1,886,273 | $77.97M | 1 | 0 | 1 | 2 | 2 |
| SENS | SENSEONICS HOLDINGS INC | 1,779,445 | $1.36K | 1 | 0 | 0 | 0 | 1 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | 1,437,613 | $54.92M | 1 | 0 | 0 | 0 | 1 |
| ABBV | ABBVIE INC | 1,376,193 | $21.38M | 2 | 8 | 8 | 1 | 21 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | 1,341,927 | $18.08K | 1 | 1 | 0 | 0 | 2 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 1,193,127 | -$74.72M | 0 | 1 | 1 | 0 | 3 |
| QSI | QUANTUM-SI INC | 1,166,140 | $2.24M | 0 | 2 | 0 | 0 | 3 |
| RXRX | RECURSION PHARMACEUTICALS-A | 1,096,094 | $11.54M | 0 | 1 | 1 | 0 | 2 |
| NKTR | NEKTAR THERAPEUTICS | 1,087,985 | -$3.70K | 0 | 1 | 0 | 0 | 2 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,044,815 | $13.32M | 0 | 2 | 0 | 0 | 2 |
| LFST | LIFESTANCE HEALTH GROUP INC | 994,937 | $8.61M | 2 | 0 | 0 | 0 | 2 |
| AKBA | AKEBIA THERAPEUTICS INC | 992,227 | $1.74K | 0 | 1 | 0 | 0 | 1 |
| ME | 23ANDME HOLDING CO -CLASS A | 977,329 | $898 | 0 | 1 | 0 | 0 | 1 |
| VKTX | VIKING THERAPEUTICS INC | 885,243 | $24.89M | 0 | 1 | 1 | 0 | 2 |
| MREO | MEREO BIOPHARMA GROUP PL-ADR | 862,863 | $1.70K | 0 | 1 | 0 | 0 | 1 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 836,200 | $18.82M | 0 | 1 | 0 | 1 | 1 |
| TDOC | TELADOC HEALTH INC | 813,071 | -$17.74M | 0 | 3 | 3 | 0 | 7 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 786,825 | $1.19M | 1 | 2 | 0 | 0 | 3 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 760,064 | $9.71M | 0 | 1 | 1 | 0 | 3 |
| VXRT | VAXART INC | 729,048 | -$4.60K | 0 | 1 | 1 | 0 | 2 |
| AQST | AQUESTIVE THERAPEUTICS INC | 711,396 | $1.44K | 0 | 1 | 0 | 0 | 1 |
| CMRX | CHIMERIX INC | 705,538 | $785 | 0 | 1 | 0 | 0 | 1 |
| CI | THE CIGNA GROUP | 695,453 | $499.30M | 0 | 5 | 3 | 1 | 10 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 669,650 | -$986.78K | 0 | 2 | 1 | 0 | 3 |
| VERV | VERVE THERAPEUTICS INC | 668,760 | $31.95M | 0 | 1 | 0 | 0 | 1 |
| AVIR | ATEA PHARMACEUTICALS INC | 637,682 | $12.09K | 0 | 2 | 0 | 0 | 2 |
| BLUE | BLUEBIRD BIO INC | 584,117 | $128.29K | 1 | 1 | 0 | 0 | 2 |
| PRME | PRIME MEDICINE INC | 526,922 | $12.24M | 0 | 1 | 0 | 0 | 1 |
| TGTX | TG THERAPEUTICS INC | 509,287 | -$391.45K | 1 | 0 | 0 | 1 | 1 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 505,689 | $23.74M | 0 | 5 | 7 | 0 | 14 |
| JYNT | JOINT CORP/THE | 478,824 | $7.06M | 0 | 2 | 0 | 1 | 2 |
| TALK | TALKSPACE INC | 460,259 | -$2.64K | 0 | 1 | 0 | 1 | 1 |
| CARA | CARA THERAPEUTICS INC | 430,308 | -$3.51M | 0 | 2 | 0 | 0 | 2 |
| ALT | ALTIMMUNE INC | 382,400 | $1.16K | 0 | 1 | 0 | 0 | 1 |
| IQV | IQVIA HOLDINGS INC | 381,555 | $147.56M | 0 | 4 | 2 | 0 | 6 |
| PFMT | PERFORMANT FINANCIAL CORP | 369,080 | $241.59K | 0 | 1 | 1 | 0 | 2 |
| ATYR | ATYR PHARMA INC | 368,700 | $806 | 0 | 1 | 0 | 0 | 1 |
| RMD | RESMED INC | 360,316 | $21.67M | 0 | 6 | 0 | 0 | 6 |
| ATEC | ALPHATEC HOLDINGS INC | 354,600 | -$732 | 1 | 0 | 1 | 0 | 2 |
| EQ | EQUILLIUM INC | 353,531 | $266 | 0 | 1 | 0 | 0 | 1 |
| A | AGILENT TECHNOLOGIES INC | 344,124 | -$34.24M | 0 | 3 | 3 | 1 | 8 |
Frequently asked questions about Most bought healthcare stocks in Q2 2023
What are the most bought Healthcare stocks in Q2 2023?
The most bought healthcare stocks in Q2 2023 are those with the largest increase in reported share counts across institutional investors compared to Q1 2023, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2023?
Among filers in this sector, net additions were largest in companies such as AVANTOR INC (AVTR), PRIVIA HEALTH GROUP INC (PRVA), DANAHER CORP (DHR), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2023).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.